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phytopathogenic Erwinia spp. by the biocontrol
rhizobacterium Paenibacillus polymyxa M-1
Ben Niu1,2,7, Joachim Vater3, Christian Rueckert4, Jochen Blom4, Maik Lehmann5, Jin-Jiang Ru1, Xiao-Hua Chen2,
Qi Wang1* and Rainer Borriss2,6*Abstract
Background: Nine gene clusters dedicated to nonribosomal synthesis of secondary metabolites with possible
antimicrobial action, including polymyxin and fusaricidin, were detected within the whole genome sequence of the
plant growth-promoting rhizobacterium (PGPR) Paenibacillus polymyxa M-1. To survey the antimicrobial compounds
expressed by M-1 we analyzed the active principle suppressing phytopathogenic Erwinia spp.
Results: P. polymyxa M-1 suppressed the growth of phytopathogenic Erwinia amylovora Ea 273, and E. carotovora,
the causative agents of fire blight and soft rot, respectively. By MALDI-TOF mass spectrometry and reversed-phase
high-performance liquid chromatography (RP-HPLC), two antibacterial compounds bearing molecular masses of
1190.9 Da and 1176.9 Da were detected as being the two components of polymyxin P, polymyxin P1 and P2,
respectively. The active principle acting against the two Erwinia strains was isolated from TLC plates and identified
by postsource decay (PSD)-MALDI-TOF mass spectrometry as polymyxin P1 and polymyxin P2. These findings were
corroborated by domain structure analysis of the polymyxin (pmx) gene cluster detected in the M-1 chromosome
which revealed that corresponding to the chemical structure of polymyxin P, the gene cluster is encoding D-Phe in
position 6 and L-Thr in position 7.
Conclusions: Identical morphological changes in the cell wall of the bacterial phytopathogens treated with either
crude polymyxin P or culture supernatant of M-1 corroborated that polymyxin P is the main component of the
biocontrol effect exerted by strain M-1 against phytopathogenic Erwinia spp.Background
The plant growth-promoting rhizobacterium Paenibacillus
polymyxa, formerly known as Bacillus polymyxa [1], can
promote plant growth by producing indole-3-acetic acid
(IAA) [2] and volatile compounds [3]. It is also known for
controlling plant-parasitic nematodes [4,5] and fungal
phytopathogens including Fusarium oxysporum [6], Fusar-
ium graminearum [7], Aspergillus niger [8], Penicillium
expansum [9], Leptosphaeria maculans [10], Phytophthora
palmivora and Pythium aphanidermatum [11]. P. polymyxa
has been recently used to control bacterial phytopathogens* Correspondence: wangqi@cau.edu.cn; rainer.borriss@rz.hu-berlin.de
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reproduction in any medium, provided the orsuch as Xanthomonas campestris [12], and X. axonopodis
[13]. The antagonistic effect of P. polymyxa against
phytopathogens is mainly due to its capability to produce
antimicrobial substances, such as peptide antibiotics and
antimicrobial proteins. P. polymyxa can produce several
kinds of peptide antibiotics, including polymyxins [14-22],
gavaserin and saltavidin [23], jolipeptin [24], gatavalin [25]
and fusaricidins [26,27].
Polymyxins which are known for their strong inhibiting
effects against gram-negative bacteria have been used to
treat multidrug-resistant gram-negative bacteria [28] and to
prevent septic shock [29]. The molecular structure of poly-
myxin is comprised of a cyclic peptide chain and a hydro-
phobic tail. Each member of polymyxins differs in the
structures of fatty acids and the variations in the amino
acid residues [30]. Polymyxins are synthesized by the
nonribosomal peptide synthetase (NRPS) mechanism [31].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 In vitro antagonistic effect of P. polymyxa M-1 against
E. amylovora Ea273 and E. carotovora. (A) Inhibiting effect of M-1
culture supernatant (CS) against E. amylovora Ea273. (B) Inhibiting
effect of M-1 culture supernatant against E. carotovora. “M-1CS”
represents M-1 GSC culture supernatant. GSC medium was used as a
negative control. M-1 cells were also spotted onto lawns of E.
amylovora Ea273 and E. carotovora. E. coli DH5α cells were used as a
negative control.
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polymyxin A [28], and polymyxin B [32] are known.
Among the 202 bacterial strains isolated from surface
sterilized wheat plants collected from Beijing and Henan
Province, China, one strain designated M-1 was selected
due to its inhibiting effect against fungal phytopatho-
gens. Growth of wheat was also enhanced in the pres-
ence of this strain indicating its plant growth promoting
activity [33]. The whole genome of P. polymyxa M-1 has
been sequenced, and nine giant gene clusters involved in
non-ribosomal synthesis of antimicrobial lipopeptides
and polyketides have been detected [34]. Due to its rich
spectrum of secondary metabolites with antimicrobial
action, P. polymyxa M-1 is a good candidate for bio-
controlling fire blight, a serious disease in apple and pear
caused by Erwinia amylovora. Previously, we have
shown that the polyketide difficidin and the dipeptide
bacilysin produced by Bacillus amyloliquefaciens sup-
press growth of E. amylovora [35]. Here, we report that
P. polymyxa M-1 synthesizes two components of poly-
myxin P, polymyxin P1 and P2, which are efficient against
E. amylovora. Moreover, the corresponding polymyxin
synthetase gene cluster in M-1 was identified and further
characterized by domain analysis as being different from
the pmx gene clusters encoding polymyxin A and B,
respectively.
Results
Characterization of M-1
Culture supernatants of M-1 suppressed growth of
several bacteria, including the human opportunistic
pathogen Pseudomonas aeruginosa (Table 1). Remark-
ably, growth of phytopathogenic E. amylovora Ea 273
and E. carotovora was strongly inhibited (Figure 1). M-1
was identified as P. polymyxa by its 16S rDNA sequence
(gb accession: FR727737) and by physiological and
biochemical features. The motile, rod-shaped and spore-
forming bacterium was facultative anaerobic, was positiveTable 1 Antibacterial activity of Paenibacillus polymyxa
M-1 culture supernant determined in agar diffusion test
Indicator strains Diameter of the inhibition zone (mm)
Erwinia amylovora Ea 273 21.5
Erwinia carotovora 20
Escherichia coli K12 18
Pseudomonas aeruginosa 23
Streptococcus faecalis 7
Micrococcus luteus 22.5
Bacillus megaterium 14.5
Bacillus subtilis 168 7.5
Bacillus amyloliquefaciens FZB42 6in the Voges-Proskauer reaction (acetylmethylcarbinol), able
to hydrolyze starch and to utilize glucose, xylose, glycerol,
and mannitol, but did not grow at sodium chloride concen-
trations exceeding 5%. The whole genome sequence of M-1
(gb accession: HE577054.1) displayed close similarity to the
sequences of plant-associated P. polymyxa strains SC2 [36]
and E681 [3], respectively.Detection and structural characterization of polymyxin P
The metabolites produced by P. polymyxa M-1, possessing
antagonistic activities against E. amylovora Ea273 and
E. carotovora were identified by matrix-assisted laser
desorption ionization-time of flight mass spectrometry
(MALDI-TOF-MS) in combination with bioautography.
Antibacterial activities were detected in both cell-surface
extracts and a GSC culture supernatant of M-1. Cell surface
extracts were prepared by extraction of cells picked from
agar plates with 70% acetonitrile/0.1% trifluoroacetic acid
[37]. By MALDI-TOF-MS, two prominent series of
mass peaks were detected, ranging from m/z = 883.1 to
983.5 (series 1) and from m/z = 1177.9 to 1267.9 (series 2)
(Figure 2A), respectively. Members of series 1 were
attributed to the well-known fusaricidins (unpublished
data), a family of lipodepsipeptides exhibiting potent anti-
fungal activities [38]. The compounds of series 2 (Figure 2B)
were investigated by MALDI-TOF-MS in more detail. Two
metabolites were detected, of which the protonated
forms showed masses of m/z = 1191.9 and m/z = 1177.9.
The other mass peaks of series 2 could be attributed to the
alkali adducts of these compounds as indicated in
Figure 2B. Their structures were determined by postsource
decay (PSD)-MALDI-TOF-MS analysis and compared with
Figure 2 MALDI-TOF-MS analysis of P. polymyxa M-1 secondary metabolites. (A) Culture supernatant of M-1 grown in GSC medium
containing fusaricidin (series 1, from m/z = 883.1 to 983.5) and polymyxin P (series 2, from m/z = 1177.9 to 1267.9) derived mass peaks.
(B) Extended view of the mass peaks m/z forming series 2. Two polymyxin P metabolites [M + H]+ m/z 1177.9 and 1191.9, and their alkali adducts
[M + Na]+ m/z 1199.9 and 1213.9, [M + K]+ m/z 1229.9, and [M-H + 2 K]+ m/z 1253.9 and 1267.9 were distinguished. The nature of the trailing
peaks next to the peaks of interest is unknown.
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cially available (Figure 3).
The fragment spectra of both the M-1 products of
series 2 and polymyxin B as the reference revealed the
presence of imino ions of threonine (m/z = 74.1) and
phenylalanine (m/z = 120.3) as well as dipeptide ions of
Dab-Dab (2,4 diaminobutyric acid, m/z = 201.4), Dab-
Thr (m/z = 202.2) and Dab-Phe (m/z = 248.3). The M-1
-products and polymyxin B differed in the dipeptide
fragments Phe-Thr (m/z = 249.4) (M-1) and Phe-Leu (m/
z = 261.1) (polymyxin B). These comparative nearest
neighbour relationships imply that the compounds of
series 2 belong to the polymyxin family which are well
known antibiotics produced by P. polymyxa. This con-
clusion was confirmed by fragment analysis using PSD-
MALDI-TOF mass spectrometry. Figure 3 shows the
peptide sequence of the M-1 metabolite with the mass
number of m/z = 1191.9 and the polymyxin B with m/z
= 1203.9 as well as of their sodium adducts. In each caseFigure 3 In situ structural analysis of polymyxins by PSD-MALDI-TOF
(with m/z of 1191.9 and 1213.9); (B) commercial polymyxin B (with m/z of
from a series of N- and C-terminal fragments [bn - and Yn -ions]. FA, fatty athe best results were accomplished in mass spectromet-
ric sequencing, when a break of the peptide bond be-
tween residue 4 and the C-terminus is assumed. The
sequence of the resulting linearized peptide follows resi-
dues 1–10. The most significant and almost complete
sequence information was obtained in the case of the bn
– ions, when fragmentation starts between Dab1 and
Thr2. For the Yn – ions the best results were achieved,
when fragmentation begins between Thr10 and Dab9. In
this way -Dab1-Thr2-Dab3-Dab4-Dab5-Phe6-Thr7-Dab8-
Dab9-Thr10- was determined as the peptide sequence of
the two M-1 – metabolites of series 2, which can be at-
tributed to polymyxin P containing Phe, Thr and Dab in
a molecular ratio of 1 : 3 : 6 [14]. In this way, these
metabolites could be identified as two isomers of poly-
myxin P, designated as polymyxin P1 and P2. The mass
spectrum of the reference compound polymyxin B also
showed two mass peaks at m/z = 1189.3 (B1) and 1203.9
(B2). They were attributed to two variants of polymyxinmass spectrometry. (A) Lipopeptide produced by P. polymyxa M-1
1203.9 and 1225.9) used as the reference. The structures were derived
cid.
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either an iso-octanoyl (C8H15O) or a 6-methyloctanoyl
(anteisononanoyl, C9H17O) residue [21,32]. By compari-
son with polymyxin B and other members of the poly-
myxin family, we conclude that polymyxin P1 and P2
from strain M-1 contain the same fatty acid residues
consistent with the data reported by Kimura et al. for
polymyxin P [14].
The anti-Erwinia activity of polymyxin P produced by
P. polymyxa M-1
In order to identify the compounds which suppress the
growth of E. amylovora Ea273 and E. carotovora in M-1
GSC culture, the supernatant was subjected to thin layer
chromatography (TLC) in combination with bioautography
[39] (Figure 4). One spot exhibiting antibacterial activity
was observed at Rf 0.36 (Figure 4A) which was identical
with that of polymyxin P [14]. It was scraped off from the
thin layer plate. The silica gel powder obtained was
extracted with methanol, and the extract was analyzed by
MALDI-TOF-MS. The obtained mass spectrum ranging
from m/z = 850 to 1350 (Figure 4B) indicates the same
mass peaks at m/z = 1199.9, m/z = 1213.9, m/z = 1239.9, m/
z = 1253.9 and m/z = 1268.0 as previously been detected for
series 2 in Figure 2. From these results we conclude, that
polymyxin P1 and P2 represent the active compounds
inhibiting growth of the Erwinia test strains. There were noFigure 4 Detection of the anti-Erwinia metabolite produced by P. pol
bioautography. Supernatants prepared from strain M-1 grown in GSC medi
strain E. carotovora. The inhibiting band at Rf 0.36 was circled. (B) MALDI-TO
by bioautography.mass signals pointing to fusaricidines (m/z = 850 – 1000) or
other metabolites showing antibacterial activity (Figure 4B).
Thus, polymyxin P was proven to be an anti-Erwinia me-
tabolite which was produced by M-1.
To corroborate these results, a GSC culture super-
natant of M-1 was fractionated by reversed-phase
high-performance liquid chromatography (RP-HPLC)
(Figure 5A). Fifteen fractions were obtained. The
fraction appearing at a retention time of 2 displayed
antagonistic effects against the growth of the two phy-
topathogenic Erwinia indicator strains (Figure 5B).
This fraction was analyzed by high-performance liquid
chromatography electrospray ionization mass spec-
trometry (HPLC-ESI-MS). Two peaks were detected at
m/z = 1191.8 and m/z = 1177.9, which also correspond
to the two isomers of polymyxin P [14] (Figure 5C).
Morphological changes of Erwinia strains caused by
treatment with crude polymyxin P
The effect of the crude polymyxin P prepared by RP-HPLC
described above against two phytopathogenic Erwinia
strains was studied by scanning electron microscopy
(SEM). Cell surfaces of both untreated E. amylovora Ea 273
and E. carotovora appeared smooth without any visible ir-
regularities (Figure 6A and D). However, dense projections
were observed on cell surfaces of the two phytopathogens
treated with crude polymyxin P (Figure 6B and E) orymyxa M-1. (A) Detection of the antibacterially acting metabolite by
um for 36 h were separated by TLC and sandwiched with indicator
F-MS analysis of the antibacterial compounds detected
Figure 5 RP-HPLC analysis and antibacterial activity test of fractions. (A) RP-HPLC (HPLC type: Agilent 1100) analysis of M-1 GSC culture
supernatant using a Luna C18 column (100 Å 150 × 4.6 mm, Phenomenex, Aschaffenburg, Germany). (B) Antibacterial activity test of HPLC fractions
of M-1 GSC culture supernatant. 15 paper discs loaded with HPLC fractions were put onto LB agar mixed with the two Erwinia strains. The numbers below
paper discs indicate different fractions. Fractions 3 corresponding to the peak at retention time 2 min in the M-1 culture supernatant HPLC chromatogram
showed antagonistic effects against the growth of E. amylovora Ea273 (left) and E. carotovora (right). “+ ” represents positive control, discs loaded with M-1
culture supernatant, while “-” represents negative control, discs loaded with sterile water. (C) HPLC-ESI-MS analysis of fraction 3.
Figure 6 Morphological changes of the Erwinia strains treated with polymyxin P and M-1 GSC culture supernatant. (A) Untreated E.
amylovora Ea273; (B) E. amylovora Ea273 treated with crude polymyxin P; (C) E. amylovora Ea273 treated with M-1 GSC culture supernatant; (D)
Untreated E. carotovora; (E) E. carotovora treated with crude polymyxin P; (F) E. carotovora treated with M-1 GSC culture supernatant. Protrusions
on cell surfaces of E. amylovora Ea273 and E. carotovora treated with crude polymyxin P and M-1 GSC culture supernatant were marked
by arrows.
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(Figure 6C and F) suggesting that polymyxin P caused the
same morphological change as M-1 GSC culture super-
natant did. Similar morphological changes were also found
on cell surfaces of Salmonella typhimurium, Escherichia
coli B [40], Chlamydia psittaci [41] and Pseudomonas
aeruginosa treated with polymyxin B or E [42].
The observed morphological changes at the surface of
the Erwinia cells treated with polymyxin support an ac-
tion mechanism in which polymyxin, bound at the
lipopolysaccharide component of the outer membrane
(OM), does permeabilize the OM [30] and - as shown
here - generates visible protrusions.
Characterization of the gene cluster encoding polymyxin
biosynthesis in P. polymyxa M-1
The genome of P. polymyxa M-1 contains a 41 kb gene
cluster displaying overall identities of 96.41% to the well
characterized polymyxin synthetase gene cluster from P.
polymyxa E681 [28] and of 91.2% to that from P. polymyxa
PKB1 [32] on the nucleotide sequence level. Corresponding
to the pmx gene clusters of E681 and PKB1, the M-1 gene
cluster consisted of five open reading frames, pmxA, pmxB,
pmxC, pmxD and pmxE (Figure 7A). Three of them, the
genes pmxA, pmxB and pmxE were directly involved inFigure 7 Putative gene cluster for polymyxin biosynthesis in P. polym
structure of the pmx genes. Black filled arrows represent NRPS genes, while
the gene cluster within the chromosome of M-1 is indicated. (B) Domain o
polymyxin P synthesized in P. polymyxa M-1 derived by bioinformatic and c
acid. “1-10” indicate the ten amino acid moieties. Four variable sites were m
polymyxin P is replaced by Leu at the corresponding position of polymyxin
substituted by Leu at the corresponding position of polymyxin B [32]. Polynon-ribosomal peptide synthesis, while pmxC and pmxD
were encoding ABC transporters (ATPase and permease
components).
Domain analysis performed with the NRPSpredictor2
server of the university of Tuebingen [43] revealed that
the putative polymyxin synthetase of M-1 comprises ten
modules (Figure 7B). Each of them consists of three or four
domains, such as A-T-C, A-T-E-C or A-T-TE. However,
similar to the pmx gene clusters in P. polymyxa PKB1 and
P. polymyxa E681, the order and arrangement of the NRPS
encoding genes was not collinear with the amino acids
in the polymyxin end product. PmxA, a polypeptide
containing 5010 amino acids, comprised four modules. The
substrate specificities of the four adenylation domains
(A-domain) were predicted to activate the amino acid
substrates D-Phe-6, L-Thr-7, L-Dab-8 and L-Dab-9,
respectively. PmxB, a polypeptide consisting of 1102 amino
acids, contained the remaining part of the last module
including a thioesterase domain (TE-domain), A-T-TE. The
A-domain was predicted to activate L-Thr-10. PmxE,
a 6312 amino-acid polypeptide, contained five modules
responsible for the first five amino acids of polymyxin P. In
addition, a N-terminal condensation domain with similarity
to starter C-domain simultaneously acylating the first
amino acid with a fatty acid tail was identified [44]. The fiveyxa M-1 and primary structure of polymyxin P. (A) Genetic
white arrows represent ABC transporter-like genes. The position of
rganization of the putative Pmx enzymes. (C) Primary structure of
hemical analysis. FA, fatty acid, 6-methyloctanoic acid or isooctanoic
arked as “W, X, Y and Z”, respectively. Phe at the sixth position (X) of
A [28], while Thr at the seventh position (Y) of polymyxin P is
myxin A and polymyxin B are labelled as “PA” and “PB”, respectively.
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Dab-3, L-Dab-4, and L-Dab-5, respectively. Therefore, the
ten modules were arranged in the gene order pmxE-pmxA-
pmxB (Figure 7B). There were two epimerization domains
(E-domains), occurring in the third and sixth module,
which indicated that the third and sixth amino acid of the
polymyxin produced by M-1 represented D-forms, D-Dab
and D-Phe, respectively. The TE-domain located at the
carboxy-terminal region of PmxB was probably responsible
for terminating polymyxin synthesis by cyclization and
releasing the product. The domain organization analysis of
the putative polymyxin synthetase from M-1 implied that
the lipopeptide synthesized by the synthetase is identical
with polymyxin P (Figure 7C) [14], which coincides
with the results obtained by mass spectrometric analysis.
Although there is high overall sequence similarity between
the polymyxin gene clusters of M-1, E681, and PKB1, the A
domains in modules 6(X) and 7(Y) activate different amino
acids. The identity between the amino acid sequences of
the sixth modules of polymyxin synthetases of M-1 and
E681, activating Phe and Leu, respectively, was only 88%.
An even lower identity of 51% on the amino acid level was
found for the A-domains of the seventh module in the
polymyxin synthetases from M-1 and PKB1, activating
either Thr or Leu, respectively.
Polymyxin antibiotics are lipopeptides, and as in case
of the two other known pmx gene clusters, no genes
were found in the vicinity of the pmx gene cluster of P.
polymyxa M-1 which might be involved in lipidation of
the peptide moiety. It is likely that polymyxin synthesis
resembles surfactin synthesis, and relies upon lipidation
functions encoded elsewhere in the chromosome [32]. Not-
ably, a thioesterase-like gene, pteH (COG3208), bearing a
GrsT domain and similar to Bacillus amyloliquefaciens
SrfAD (27% identity), was preceding a giant peptide synthe-
tase gene at 2,508,313 in the genome of M-1. However, the
PteH protein contains no acyltransferase domain and its
role in attaching the fatty acid moiety to the polymyxin
dekapeptide remains to be elusive.
Discussion
In this study, we found that growth of two important
phytopathogens, E. amylovora Ea273 and E. carotovora
was inhibited by M-1. Polymyxin P was identified as be-
ing the active principle of M-1. Two lines of evidence
supported this finding: (1) M-1 supernatants formed a
distinct clearing spot when exposed to bioautography
using the Erwinia strains as indicator. When the mater-
ial isolated from that area was analyzed by MALDI-TOF
mass spectroscopy, the mass peaks with m/z of 1199.9,
1213.9, 1253.9 and 1268.0 indicating alkali adducts of
polymyxin P were detected (Figure 4); (2) a single frac-
tion obtained by HPLC contained the inhibiting activity
against bacterial pathogens and also the characteristicmass peaks m/z were indicating the presence of poly-
myxin P in this sample (Figure 5).
Polymyxin P is a peptide antibiotic reported more
than 40 years ago, and two species with different hy-
droxy fatty acids were described. Polymyxin P1 con-
tains anteisononanoic acid, a-C9, and polymyxin P2
isooctanoic acid, i-C8 [14]. Although its constituent
amino acids have been determined as being six Dab,
three Thr, and one Phe; to the best of our knowledge,
no further investigation about the primary structure of
polymyxin P and the configuration of the constituent
amino acids has been performed until now.
Here we established the primary structure of poly-
myxin P by PSD-MALDI-TOF mass spectrometry (Fig-
ure 3). Alterations in comparison to other polymyxin
species were detected in two out of the four variable po-
sitions of the peptide. A unique Phe residue resided at
the sixth position (X), and a Thr residue was found at
the seventh position (Y) of polymyxin P. These results
were corroborated by bioinformatic analysis of the poly-
myxin synthetase gene cluster in M-1, where the
adenylation domains specified the amino acid substrates
to be activated (Table 2). The resulting order of amino
acids did completely match with the structure for poly-
myxin P obtained by PSD MALDI-TOF MS (Figure 7C).
Whilst this technique did not deliver information about
stereochemical configuration of the amino acid moieties,
our bioinformatic approach resulted in detection of two
epimerization-domains residing in the third and the
sixth module (Figure 7B), suggesting the presence of D-
Dab and D-Phe in position 3 and 6 of the polymyxin
product, respectively (Figure 7C). The occurrence of D-
Dab in position 3 corresponds with recent findings in
polymyxin A [28] and polymyxin B [32]. This is remark-
able, since according to literature, these forms of poly-
myxin are rare and the fact that all three of the
polymyxin gene clusters examined to date are from
plant-associated strains of P. polymyxa isolated for their
biocontrol and plant growth promoting activities is rele-
vant for this observation [32].
Conclusions
Our results support the view that polymyxin P encoded
by the pmxABCDE gene cluster is the main compound
in the culture filtrate of P. polymyxa M-1 in suppressing
E. amylovora and E. carotovora, the causative agents of
the important plant diseases fire blight and soft rot, re-
spectively. Since the rare polymyxin P has not been pre-
viously used as a clinical agent, in contrast to polymyxin
B and colistin [30], this finding provides a potential
option to use polymyxin P or its producer strain P.
polymyxa M-1 as an alternative of chemical bactericides
to control fire blight, soft rot and other plant diseases
caused by gram-negative bacteria.
Table 2 Specificity-conferring amino acids and homologies of the adenylation domains in polymyxin synthetases of
strains M-1, E681, and PKB1
Module/ strain Active site residues in A-domain Specified aa % aa E681 % aa PKB1
235 236 239 278 299 301 322 330
Module 1
pmxE1/M-1 D V G E I S S I L-Dab 99 99
pmxE1/E681 D V G E I S S I L-Dab
pmxE1/PKB1 D V W E I S S I L-Dab
Module 2
pmxE2/M-1 D F W N I G M V L-Thr 99 98
pmxE2/E681 D F W N I G M V L-Thr
pmxE2/PKB1 D F W N I G M V L-Thr
Module 3 (W)
pmxE3/M-1 D V G E I S S I D-Dab 98 92
pmxE3/E681 D V G E I S S I D-Dab
pmxE3/PKB1 D V G E I S S I D-Dab
Module 4
pmxE4/M-1 D V G E I S A I L-Dab 96 96
pmxE4/E681 D V G E I S A I L-Dab
pmxE4/PKB1 D V G E I S A I L-Dab
Module 5
pmxE1/M-1 D V G E I S A I L-Dab 97 89
pmxE1/E681 D V G E I S A I L-Dab
pmxE1/PKB1 D V G E I S A I L-Dab
Module 6 (X)
pmxA1/M-1 D A W T I A A I D-Phe 88 99
pmxA1/E681 D A W I V G A I D-Leu
pmxA1/PKB1 D A W T I A A I D-Phe
Module 7 (Y)
pmxA2/M-1 D F W N I G M V L-Thr 99 51
pmxA2/E681 D F W N I G M V L-Thr
pmxA2/PKB1 D G F L L G L V L-Leu
Module 8
pmxA3/M-1 D V G E I S A I L-Dab 97 92
pmxA3/E681 D V G E I S A I L-Dab
pmxA3/PKB1 D V G E I S A I L-Dab
Module 9
pmxA4/M-1 D V G E I S A I L-Dab 96 91
pmxA4/E681 D V G E I S A I L-Dab
pmxA4/PKB1 D V G E I S A I L-Dab
Module 10 (Z)
pmxB1/M-1 D F W N I G M V L-Thr 97 99
pmxB1/E681 D F W N I G M V L-Thr
pmxB1/PKB1 D F W N I G M V L-Thr
Modules 3 and 6 contained extra epimerization domains which might convert Dab3 and Phe6 to the D-configuration. A-domains in modules 6 (X) and 7(Y)
specifying different amino acids in the polymyxins produced by M-1, E681, and PKB1 are underlined.
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Bacterial strains and growth conditions
Strain M-1 isolated from surface sterilized wheat roots
in China was kept frozen at −70 C with 15% glycerol as
a laboratory stock. This strain was cultured in tryptic
soy broth (TSB) liquid medium or on tryptic soy broth
agar (TSBA) plates (TSB supplemented by 1.5% agar) at
30°C for general purposes or in glucose-starch-CaCO3
(GSC) medium [45] at 30°C for antibacterial activity
tests and chemical analysis of polymyxin. M-1 has been
deposited in China General Microbiological Culture Col-
lection Center (CGMCC) as strain CGMCC 7581. Other
strains used in this study were laboratory stocks
obtained from different sources and kept frozen with
15% (v/v) glycerol at −70°C. They were grown in Luria
broth (LB) or on LB agar plates (LB solidified with 1.5%
agar) at 30°C (E. amylovora Ea273, E. carotovora and
Micrococcus luteus) or 37°C (Pseudomonas aeruginosa,
Streptococcus faecalis, Bacillus megaterium, Bacillus
subtilis 168, Bacillus amyloliquefaciens FZB42 and Bacil-
lus cereus ATCC 14579).
Bacterial identification
Identification of the strain M-1 was carried out by using
16S rDNA sequence analysis as well as by physiological and
biochemical characterization. After growing in TSB
medium at 30°C overnight, the bacteria cells were collected
by centrifuging for chromosomal DNA isolation using the
standard phenol:chloroform procedure. Then, the 16S
rDNA was amplified by PCR with two pairs of primers
63 F (5’CAG GCC TAA CAC ATG CAA GTC-3’), 1387R
(5’GGG CGG TGA TGT ACA AGG C’-3) [46], 530 F
(5’GTG CCA GCM GCC GCG G-3’) and 1494R (5’GGY
TAC CTT GTT ACG ACT T-3’) [46,47]. The reaction
mixture included Taq DNA polymerase, 10 × Taq buffer,
forward and reverse primers, each deoxynucleoside triphos-
phate (dATP, dGTP, dCTP and dTTP) (Beijing Youbo Gene
Technology Co., Ltd) and template DNA. Amplifications
were performed using a Biometra T personal 48 thermo-
cycler (Biometra, Goettingen, Germany) with the following
cycle conditions: initial activation at 94°C for 5 min; 35
cycles of 94°C for 1 min, 55°C for 30 sec, and 72°C for
1 min; a final extension at 72°C for 10 min. PCR products
(100 μL total volume) were analyzed by electrophoresis
using a 0.8% (w/v) Tris-acetate-EDTA (TAE) agarose gel
mixed with ethidium bromide and ultraviolet visualization.
PCR products were purified from ethidium bromide-
stained gels using the DNA product purification Kit
(TIANGEN BIOTECH (BEIJING) CO., LTD) and inserted
into pMD18-T vectors (TAKARA BIOTECHNOLOGY
(DALIAN) CO., LTD). The recombinant plasmids were
transformed into E.coli DH5α. DNA sequencing of the
plasmids was done by Beijing Youbo Gene Technology Co.
Ltd. Nucleotide sequences were assembled and editedwith Gap4 which is a part of the STADEN package
(http://staden.sourceforge.net/) software. The sequences
were compared with those of the reference organisms by
Blast search.
Selection of a medium for polymyxin production
Among the seven media used in our survey, Katznelson
and Lochhead (KL) medium [48], Landy medium [49],
Landy medium either supplemented with yeast extract, D,
L-alanine and phenylalanine (Landy GA) or with yeast ex-
tract and phenylalanine (Landy G), GSC medium [45],
brain-heart infusion (BHI) medium and tryptic soy broth
yeast extract (TSBYE) medium, the GSC medium was
optimal for production of polymyxin.
Antibacterial activity assay
To investigate its antibacterial spectrum, P. polymyxa M-1
was grown in GSC medium under aerobic conditions at
30°C for 72 h. Then the culture was centrifuged at
6000 rpm at 4°C for 10 min to remove cells. Fresh indicator
bacteria plates were prepared for the assay. When the
concentration of indicator bacteria grown in LB medium at
appropriate temperature was up to 4 × 107 CFU/mL,
0.5 mL bacteria suspension was mixed with 20 mL melting
LB agar and cooled below 60°C to prepare the plates.
50 μL M-1 GSC culture supernatant were loaded into a
well punched in indicator bacteria plate which was then
incubated at 30°C overnight to observe the growth inhib-
ition effect. GSC medium without bacteria was also loaded
as a negative control. The diameters of inhibition zones
were then measured and recorded.
The inhibiting activity of M-1 against E. amylovora Ea273
and E. carotovora was also tested by spotting bacterium on
an indicator bacteria plate prepared by the method
described above. E. coli DH5α used as a negative control
was also spotted onto the lawn of indicator strains. Then
the plates were incubated at 30°C overnight to observe the
growth inhibition effect.
To analyze the antibacterial activity of the HPLC
fractions, a 50-μL aliquot of each fraction was loaded onto
sterilized paper disks. 50 μL M-1 GSC culture supernatant
used as a positive control and 50 μL sterile distilled water
used as a negative control were also loaded. After being air
dried in a clean bench, the disks were transferred onto
E. amylovora Ea273 and E. carotovora plates prepared
by the method described above and incubated at 30°C
overnight to observe growth inhibition effect.
Separation of antibacterial compounds by RP-HPLC
The chromatographic system consisted of an Agilent
1100 liquid chromatograph equipped with a diode-array
detector (Agilent Technologies, Waldbronn, Germany).
Hundred μL M-1 culture supernatant were applied to the
RP-HPLC column (Luna C18 100 Å 150 mm × 4.6 mm,
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isocratically with H2O containing 0.1% HCOOH at a flow
rate of 1 mL/min. The obtained fractions were freeze-
dried, dissolved in sterile distilled water and subjected to
an antibacterial test described above. The active fraction
was subsequently used for high performance liquid chro-
matography electrospray ionization mass spectrometry
(HPLC-ESI-MS) analysis.Bioautography
Bioautography was performed as previously described [39].
In short, M-1 GSC culture supernatant was loaded onto an
XAD16 (Sigma) resin column which was then washed and
eluted with methanol. After being dried by a rotary evapor-
ator, the samples were redissolved in methanol and spotted
onto silica gel 60 F254 thin-layer chromatography (TLC)
aluminium sheets (20 by 20 cm; Merck, Darmstadt,
Germany) and separated by TLC using n-BuOH : AcOH :
H2O= 4:1:3 containing 1/20 volume of pyridine as the
solvent system. Afterwards, strips of the TLC plates were
stuck on the surface of the LB agar containing indicator
strains at room temperature for 2 h. The LB agar plates
were then incubated at 30°C overnight. The inhibition
zones documented the positions of the antibacterial
compounds separated by TLC. Their Rf values were
calculated. The experiments were repeated at least three
times. Matrix material from the positions at which the
antibacterial compounds were located was scraped from
the silica gel, and extracted with methanol. Then the ex-
tracts were lyophilized and analyzed by MALDI-TOF-MS.MS analysis
Metabolites in culture supernatant of M-1 were investi-
gated by MALDI-TOF-MS. After M-1 was grown in GSC
medium at 30°C for 72 h, samples for mass spectrometric
analysis were taken from the culture supernatant and
used for measurements after dilution 1:10 with 50%
acetonitrile: 50% water containing 0.1% trifluoroacetic acid
(solution A). Samples from the TLC plates were diluted in
the same way.
MALDI-TOF-mass spectra were recorded using a Bruker
Autoflex instrument equipped with a 337 nm nitrogen laser
for desorption and ionization. A 2-μL aliquot of each
sample was mixed with the same volume of matrix solution
(a saturated solution of α-cyano-4-hydroxycinnamic acid in
solution A), spotted on the target, air dried and measured
as described previously [50].
Spectra were recorded by positive ion detection in re-
flector mode. The acceleration and reflector voltages were
19 and 20 kV in pulsed ion extraction mode. A molecular
gate of 350 Da improved the measurements by filtering out
most matrix ions. PSD-MALDI-TOF-MS of the polymyxinswere generated with the same samples. Monoisotopic
masses were obtained.
In addition, M-1 GSC culture supernatant and the active
fraction were analyzed by an online HPLC (1100 series
HPLC system, Agilent Technologies) coupled to a QTRAP
2000 mass spectrometer (Applied Biosystems) using a Luna
C18 100 Å 50 × 1 mm column (Phenomenex). Samples
were applied to HPLC-ESI-MS by isocratic elution with
H2O containing 0.1% formic acid at a flow rate of
60 μL/min in 10 min. MS analysis was performed in
positive ion mode with a mass window ranging from
m/z 500–1400.
Polymyxin treatment
The Erwinia strains were treated with crude polymyxin
P by the method described previously [51] with some
modification. The crude polymyxin P (final concentration:
20 μg/mL) or GSC culture supernatant of M-1 (final
concentration: 1% (v/v)) was added to LB cultures of the
Erwinia strains at OD600nm of 0.1. After being inoculated at
28°C for 2 h, the suspensions were centrifuged at 4000 rpm
for 5 min to collect bacteria which were then washed two
times before observation by SEM.
Scanning electron microscopy
For analysis by SEM, cells were spinoculated on poly-lysine
coated cover glasses and fixed with 2.5% glutaraldehyde/2%
para-formaldehyde in 100 mM cacodylate buffer (pH 7.4)
at 4°C overnight. After fixation cells were rinsed three times
for 10 minutes with 100 mM cacodylate buffer, postfixed
for 3 h in 1% osmiumtetroxide, rinsed again three times for
10 minutes with 100 mM cacodylate buffer and dehydrated
through an ethanol series. After critical point drying, cells
were coated with gold and analyzed on an LEO 1430
scanning electron microscope.
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